SMYD3 regulates the MEK/ERK kinase signaling pathway via methylation of mitogen-activated protein kinase 2 (MEKK2) in Ras-driven pancreatic ductal adenocarcinoma and lung adenocarcinoma cancers [192]. The gene discussed is MAP3K2; the disease is pancreatic ductal adenocarcinoma.